3 Ways to Accelerate Progress in the Fight Against HIV/AIDS

By Admin
There has been incredible progress in the fight against HIV/AIDS – new treatments have been discovered, more research is being funded and more ant...

There has been incredible progress in the fight against HIV/AIDS – new treatments have been discovered, more research is being funded and more antiretroviral drugs have reached those that need it most.

But for more than three decades, the deadly disease has continued to outpace efforts, with more people becoming newly infected with HIV each year than those able to be treated.

Until now.

According to a recent AIDS report by ONE, more people were added to treatment in 2013 than the number of people who became newly infected with HIV in the same year.

The report titled “At the Tipping Point: Tracking Global Resources on AIDS, Volume 3,” examined three major challenges that still lie ahead in defeating the disease: insufficient resources, increased risk for marginalized groups, and the fragility of progress as a whole.

Only 15 sub-Saharan African countries have reached the tipping point, according to the report, as opposed to all, and while this is a major feat in itself, many of the countries’ health systems remain incredibly weak.

In order to solidify the gains made in recent years and ensure more progress towards the defeat of AIDS, here are three key steps that must be taken, as outlined by the report.

1. Target HIV where it is, not where it is easiest to reach.

This includes developing tailored strategies to reach marginalized populations more effectively.

2. Deploy bold new funding from a more diversified base.

More countries – including African governments – need to increase their contributions to HIV/AIDS and health.

3. Build resilient health systems that can tackle AIDS alongside other health challenges.

Countries need to be prepared when crises arise, such as Ebola, to reduce outbreaks.

The full report can be read here

Follow us on Twitter (@HealthcareGlbl) and like us on Facebook!


Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability